Cyclic Cushing's disease in long-term remission with a daily low dose of bromocriptine

15Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

A 56-year-old male patient with cyclic Cushing's disease remained in a state of remission for more than one year with a relatively low dose of bromocriptine (2.5-3.75 mg/day). It has been reported that bromocriptine treatment for cyclic Cushing's disease induces only a transient remission; in the most effective cases, a relatively high dose (40 mg/day) was necessary. In the hypercortisolemic state, plasma adrenocorticotropic hormone (ACTH) and serum cortisol were not suppressed by dexamethasone and did not respond to corticotropin-releasing factor (CRF). An antehypophysectomy was not effective, even though the resected tissue contained ACTH-positive microadenomas. The present observations thus indicate the effectiveness of bromocriptine for some patients with this rare disorder.

Cite

CITATION STYLE

APA

Adachi, M., Takayanagi, R., Yanase, T., Sakai, Y., Ikuyama, S., Nakagaki, H., … Nawata, H. (1996). Cyclic Cushing’s disease in long-term remission with a daily low dose of bromocriptine. Internal Medicine, 35(3), 207–211. https://doi.org/10.2169/internalmedicine.35.207

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free